Muhammad Nasir Hayat Malik

15PUBLICATIONS
21CO-AUTHORS
Regenerative medicine (incl. stem cells)Biologically active moleculesMolecular medicineMolecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 04, 2026
Therapeutic potential of p-cymene in mitigating alcohol-induced damage in umbilical cord-derived mesenchymal stem cells through restoration of Nanog, VEGF, and antioxidants levels; in silico and in vitro approaches.

N Aziz, T Maqbool, M Arooj

|Feb 19, 2026
Retraction Note: Novel acetamide derivatives of 2-aminobenzimidazole prevent inflammatory arthritis in rats via suppression of pro-inflammatory mediators.

Aymun Madni Zubair, Muhammad Nasir Hayat Malik, Waqas Younis

|Jan 30, 2026
Epiafzelechin, a Flavanol, Regulates Lipid Homeostasis Through Modulation of HMGCR, PCSK9, and PPAR-α: Mechanistic Insights and Therapeutic Implications.

Saud O Alshammari, Nazifa Shahzad, Muhammad Nasir Hayat Malik

|Oct 20, 2025
p-Cymene Targets Multiple Oncogenic Pathways in Hepatocellular Carcinoma: Insights From Network Pharmacology and In Vitro Studies.

Nadia Anwar, Muhammad Nasir Hayat Malik, Muhammad Atif

|Sep 02, 2025
Charantin targets HMGCR-PCSK9 axis and activates PPAR-α signaling to ameliorate hyperlipidemia: Mechanistic insights from bioinformatics and in-vivo studies.

Ghulam Abbas, Muhammad Nasir Hayat Malik, Haya Yasin

|Jun 27, 2025
Terpinen-4-ol Targets HIF-1α/TGF-β1/TNF-α Axis to Attenuate Ethanol-Induced Hepatotoxicity: Network Pharmacology and In Vitro Validation.

Tariq G Alsahli, Maryam Khalid, Muhammad Nasir Hayat Malik

Pageof 3

Frequent Collaborators

4 joint publications

Gideon F B Solre

2 joint publications

Muhammad Atif

2 joint publications

Saud O Alshammari

2 joint publications

Irfan Anjum